MEF2C and congenital heart disease: They further suggested that miR‐20b might not only represent a novel therapeutic target for congenital heart diseases but also provide new insights into the mechanisms of cardiac diseases.38 The potential mRNA targets for miR‐17‐5p included wnt5a, MEF2C, TBX3, and HOXA3.